BWX Technologies Inc. reported first‑quarter 2026 results that surpassed expectations, with revenue rising 26% to $860.2 million and non‑GAAP earnings per share of $1.12, a $0.20 beat over the consensus estimate of $0.92. Adjusted EBITDA climbed 14% to $148.0 million, driven by robust demand across both its Government and Commercial Operations segments.
The Commercial Operations segment posted a 121% year‑over‑year revenue increase to $283.6 million, while the Government Operations segment grew 4% to $576.6 million. Overall adjusted EBITDA margin contracted from 19.0% to 17.2% due to a shift toward lower‑margin government work, but the Commercial segment’s margin expanded to 12.9% from 10.9% and the Government segment maintained a strong 20.4% margin.
Management attributed the earnings beat to improved throughput, favorable pacing of work, and exceptional operational execution. The company’s backlog reached $8.7 billion, up 77% year‑over‑year, providing clear visibility to future growth and supporting the raised guidance.
Guidance for 2026 was increased: adjusted EBITDA is now projected at $650 million to $665 million, and diluted EPS at $4.60 to $4.75. Free cash flow is expected to be $315 million to $330 million. The company also highlighted its expansion in commercial nuclear manufacturing, the acquisition of Precision Components Group, and plans for a new plant in Mount Vernon, Indiana.
"We had a great start to 2026 with very strong first quarter results. Revenue grew 26%, 11% of which was organic. Adjusted EBITDA grew 14%, and earnings per share grew 22%, all ahead of expectations. Our performance in the quarter was driven by improved throughput, favorable pacing of work, and exceptional operational execution across our business lines," said President and CEO Rex Geveden. "For adjusted EBITDA, we are increasing the guidance range by $5 million on each end, resulting in revised adjusted EBITDA guidance of $650 million to $665 million," added CFO Mike Fitzgerald. "These assumptions lead to non‑GAAP earnings per share guidance of $4.60 to $4.75," he continued.
The results underscore BWX Technologies’ strong demand for nuclear fuel, components, medical isotopes, and small‑modular‑reactor parts. The raised guidance and growing backlog signal confidence in continued growth, while the strategic acquisition of Precision Components Group and planned manufacturing expansion position the company to meet the expanding global nuclear market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.